JY
GBT

Jeff Yass’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Jeff Yass’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-282,600
Closed -$19.2M – 14657
2022
Q3 		$19.2M Buy
282,600
+209,500
+287% +$11.6M 0.01% 1457
2022
Q2 		$2.34M Buy
73,100
+53,700
+277% +$1.57M ﹤0.01% 4587
2022
Q1 		$672K Sell
19,400
-43,100
-69% -$1.29M ﹤0.01% 8190
2021
Q4 		$1.83M Sell
62,500
-37,500
-38% -$1.16M ﹤0.01% 5725
2021
Q3 		$2.55M Buy
100,000
+11,900
+14% +$350K ﹤0.01% 5308
2021
Q2 		$3.08M Sell
88,100
-120,000
-58% -$4.69M ﹤0.01% 4961
2021
Q1 		$8.48M Sell
208,100
-40,900
-16% -$1.88M ﹤0.01% 3043
2020
Q4 		$10.8M Buy
249,000
+61,900
+33% +$3.05M ﹤0.01% 2409
2020
Q3 		$10.3M Buy
187,100
+7,100
+4% +$451K ﹤0.01% 2133
2020
Q2 		$11.4M Sell
180,000
-44,400
-20% -$3.05M ﹤0.01% 1999
2020
Q1 		$11.5M Sell
224,400
-60,900
-21% -$4.08M ﹤0.01% 1601
2019
Q4 		$22.7M Buy
285,300
+39,900
+16% +$2.36M 0.01% 1304
2019
Q3 		$11.9M Buy
245,400
+52,000
+27% +$2.71M ﹤0.01% 1794
2019
Q2 		$10.2M Sell
193,400
-173,200
-47% -$9.95M ﹤0.01% 1867
2019
Q1 		$19.4M Buy
366,600
+235,800
+180% +$11.6M 0.01% 1215
2018
Q4 		$5.37M Sell
130,800
-149,300
-53% -$5.59M ﹤0.01% 2207
2018
Q3 		$10.6M Sell
280,100
-206,200
-42% -$9.13M ﹤0.01% 1859
2018
Q2 		$22M Buy
486,300
+219,300
+82% +$9.99M 0.01% 1219
2018
Q1 		$12.9M Sell
267,000
-162,100
-38% -$9.04M ﹤0.01% 1572
2017
Q4 		$16.9M Buy
429,100
+327,800
+324% +$12.2M 0.01% 1385
2017
Q3 		$3.15M Sell
101,300
-78,200
-44% -$2.2M ﹤0.01% 3162
2017
Q2 		$4.91M Sell
179,500
-117,400
-40% -$3.49M ﹤0.01% 2437
2017
Q1 		$10.9M Buy
296,900
+260,600
+718% +$6.56M 0.01% 1540
2016
Q4 		$525K Buy
36,300
+9,000
+33% +$158K ﹤0.01% 6875
2016
Q3 		$629K Sell
27,300
-53,600
-66% -$1.02M ﹤0.01% 5644
2016
Q2 		$1.34M Buy
+80,900
New +$1.63M ﹤0.01% 4276

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Jeff Yass's GBT Position: Q4 2022 in Review

Jeff Yass sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 47,540 shares — an estimated $3.24M sold.

Jeff Yass first reported a position in GBT in Q3 2015 and held it in 21 quarters. The position peaked at $11.7M in Q2 2019. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Jeff Yass reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Jeff Yass sold 47,540 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $3.24M.
  • Jeff Yass first reported a position in Global Blood Therapeutics, Inc. in Q3 2015 and held it in 21 quarters.
  • Jeff Yass's Global Blood Therapeutics, Inc. position peaked at $11.7M in Q2 2019.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.